
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PHF24 CRISPR/Cas9 KO Plasmid (h) | sc-409845 | 20 µg | $397.00 |
PHF24 (PHD finger protein 24) is a nuclear protein that contains a PHD-type zinc finger, a motif frequently involved in recognizing histone modifications and coordinating chromatin-dependent regulation of transcription. By linking epigenetic state to gene expression programs, PHF24 is positioned to influence neuronal differentiation, synaptic signaling, and activity-dependent transcriptional responses that shape cellular identity. Altered regulation of chromatin readers and transcriptional control networks has been implicated in neurodevelopmental and neuropsychiatric phenotypes, making PHF24 relevant for mechanistic studies of brain-associated pathways. Dissecting PHF24 function can help clarify how epigenetic interpretation interfaces with transcriptional circuitry and downstream cellular phenotypes.
PHF24 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PHF24 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PHF24 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PHF24 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PHF24 protein expression.
This CRISPR knockout system enables efficient generation of PHF24-deficient cell models for investigation of PHF24 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.